Covance Data and Technology

Services

Daten und Technologie

Covance utilizes unrivaled, proprietary data and technology to improve clinical study outcomes.

Xcellerate Technology Suite

Xcellerate® is a suite of data and technology enabling solutions designed to increase drug and medical device development efficiency, reduce timelines, improve compliance, and drive commercialization.

By the Numbers

Site Activation to Last Patient in

4,2

Months Faster vs. The Industry
Oncology - Global - Phase I-IV

Recruitment Rate

14 %

Faster vs. The Industry
Oncology - Global - Phase I-IV

Screen Failure

26 %

Fewer vs. The Industry
Oncology - Global - Phase I-IV

Patient Density

63 %

Better vs. The Industry
Cardiology - Global - Phase I-IV

Photo of computer monitor with charts and graphs

Featured Webinar

Measuring Success of a Quality Risk Management Approach

As regulatory guidance and data collection in clinical trials has evolved, sponsors face pressure to balance quality, productivity and cost for risk management and monitoring. The industry has adopted risk-based quality management (RBQM), yet the methodology is inconsistent. There is no standard way to measure the impact of the different approaches to RBQM on the effectiveness of clinical trial management. Learn more about our approach to establishing and tracking metrics - including those that could apply across the industry - to measure the success of an RBQM approach.

Watch webinar

Testimonial

„Kein anderer Anbieter hat vergleichbare Kenntnis über die Gründe, warum sich Patienten für oder gegen die Teilnahme an einer klinischen Studie entscheiden. This is a differentiator and extremely innovative" VP, Top 5 Pharma

Demo-Anfrage

Increase the efficiency and effectiveness of your clinical trials with Xcellerate

Mehr erfahren